ストックスクリーナーアプリを入手
4.72
9.23%
-0.48
アフターアワーズ：
4.68
-0.04
-0.85%
Orchestra Biomed Holdings Inc (OBIO) 最新ニュース
Orchestra BioMed Welcomes Christopher Cleary to Board of Directors - MSN
Orchestra BioMed to Participate in Upcoming Investor Conferences - MSN
Orchestra BioMed to Present at Upcoming Investor Conferences - GlobeNewswire
3 Major Healthcare Conferences Where Orchestra BioMed Will Share Its Growth Story - StockTitan
Dr. Vivek Reddy Joins Orchestra BioMed to Lead Breakthrough Hypertension Study - MyChesCo
Orchestra BioMed Appoints Vivek Reddy, M.D. as Executive - GlobeNewswire
Mount Sinai's Top Cardiac Expert Takes Helm of Groundbreaking Hypertension Treatment Study - StockTitan
Orchestra BioMed (NASDAQ:OBIO) Shares Up 5.1%Time to Buy? - MarketBeat
Orchestra BioMed Unveils Groundbreaking Data on AVIM Therapy’s Potential to Prevent Heart Failure - MSN
SG Americas Securities LLC Has $51,000 Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra BioMed (NASDAQ:OBIO) Trading 5.1% Higher – Here’s Why - Defense World
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Sees Large Decline in Short Interest - Defense World
How the (OBIO) price action is used to our Advantage - Stock Traders Daily
Individual investors among Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) largest stockholders and were hit after last week's 11% price drop - Simply Wall St
Orchestra BioMed Says AVIM Therapy Improves Echo Markers of Diastolic Dysfunction - Marketscreener.com
Orchestra BioMed Announces Data Demonstrating Favorable - GlobeNewswire
Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference - GlobeNewswire
Clinical Data: Orchestra BioMed's AVIM Therapy Shows Significant Heart Failure Prevention Benefits | OBIO Stock News - StockTitan
Orchestra BioMed Announces Appointment of Former Medtronic - GlobeNewswire
Orchestra BioMed Appoints New Director Amid Board Changes - TipRanks
Christopher Cleary Joins Orchestra BioMed Board of Directors, Enhancing Strategic Leadership in Medical Device Innovations - Nasdaq
Medtronic M&A Veteran Who Led $60B+ in Deals Joins Orchestra BioMed Board - StockTitan
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Orchestra BioMed Reports Q3 2024 Results, Advances Key Clinical Programs - MSN
Barclays PLC Increases Stock Position in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
When (OBIO) Moves Investors should Listen - Stock Traders Daily
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Shares Sold by Jane Street Group LLC - Defense World
(OBIO) Investment Analysis - Stock Traders Daily
Geode Capital Management LLC Purchases 11,002 Shares of Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Barclays PLC Increases Stake in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
US Penny Stocks Spotlight: AC Immune And Two Others To Consider - Simply Wall St
Orchestra BioMed (NASDAQ:OBIO) Coverage Initiated by Analysts at Barclays - Defense World
Barclays Initiates Coverage of Orchestra BioMed Holdings (OBIO) with Overweight Recommendation - MSN
Orchestra BioMed shares get shot in the arm on solid clinical trial data - Mugglehead
Orchestra BioMed Up 49% After Barclays Starts Coverage With $16 Target - MarketWatch
Stock market news: Rain Oncology +371.17%, SuperCom +75.93% among top gainers during mid day trading - Business Upturn
Orchestra BioMed (NASDAQ:OBIO) Now Covered by Barclays - MarketBeat
This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Orchestra Orchestra BioMed stock rated Overweight on novel medtech model By Investing.com - Investing.com Nigeria
State Street Corp Has $2.21 Million Stock Holdings in Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) - Defense World
Orchestra Biomed CEO David Hochman buys $18,640 in common stock By Investing.com - Investing.com Australia
Orchestra Biomed CEO David Hochman buys $18,640 in common stock - Investing.com India
Insider Buying: Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) Insider Purchases 4,000 Shares of Stock - MarketBeat
Orchestra BioMed Holdings, Inc.'s (NASDAQ:OBIO) top owners are individual investors with 26% stake, while 22% is held by hedge funds - Yahoo Finance
Orchestra BioMed CFO Taylor Lawrence buys $4,830 in company stock - Investing.com
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):